Topics

PAVmed Successfully Completes Clinical Safety Study Procedures for CarpX™ 510(k) Re-submission

04:30 EDT 15 Aug 2019 | BioMedReports - Blog

All 20 patients underwent successful CarpX procedures while passing primary effectiveness endpoint, with all follow-up patients to date passing primary safety endpoint

NEW YORK, Aug. 15, 2019 (GLOBE NEWSWIRE)

Read more...

Original Article: PAVmed Successfully Completes Clinical Safety Study Procedures for CarpX™ 510(k) Re-submission

NEXT ARTICLE

More From BioPortfolio on "PAVmed Successfully Completes Clinical Safety Study Procedures for CarpX™ 510(k) Re-submission"

Quick Search